Source: https://www.butlersnow.com/attorney/adam-spicer/
Timestamp: 2019-04-24 18:41:37+00:00

Document:
Adam is a dynamo and a very formidable adversary. In addition to his rare oratorical skills, Adam is also a thoughtful advocate with impressive judgment and tireless dedication. He is further set apart by his temperament. His courteousness, empathy, and passionate work ethic have endeared him to company witnesses, Merck personnel and other lawyers with whom he works. The enthusiasm Adam generates is not only attributable to his legal acumen, but just as importantly his commitment to the highest ethical and professional standards. Adam is an impressive talent. We’re glad he’s on our side.
Adam is a trial lawyer who has been entrusted by clients to serve as trial counsel in high-exposure cases involving complex scientific, medical, and regulatory issues in particularly challenging venues. His recent trial experience includes serving as trial counsel in a pelvic mesh case in the Philadelphia Court of Common Pleas that resulted in a hung jury and mistrial in September of 2018.
Adam focuses his practice on representing pharmaceutical, medical device, agricultural, and chemical manufacturers in mass tort and individual cases in various state and federal venues throughout the country. He also has significant experience defending pharmaceutical and medical device manufacturers in state Attorneys General actions.
Adam is active in numerous professional organizations, including Defense Research Institute (DRI), where he serves as a member of the Drug and Medical Device Committee’s Steering Committee. He is also a member of the International Association of Defense Counsel (IADC) and the American Bar Association (ABA) and previously served as co-chair of the ABA’s Pharmaceutical and Medical Device Subcommittee. He is also a member of the National Bar Association, Mississippi Bar Association, Magnolia Bar Association and Capital Area Bar Association.
A graduate of the prestigious International Association of Defense Counsel (IADC) Trial Academy (2010), Adam is recognized by several industry publications, including Mid-South Super Lawyers Rising Stars and Portico Magazine’s Top 10 “Up-and-Coming” Attorneys (2014). He was a member of Leadership Mississippi’s class of 2010-2011.
Representation of pharmaceutical, medical device, and cosmetics manufacturers in various state Attorney General actions.
Trial counsel for Johnson & Johnson and Ethicon, Inc. in McFarland et al. v. Ethicon Inc. et al., Case No. 130701577, Court of Common Pleas of Philadelphia, Pennsylvania, involving pelvic mesh; hung jury and mistrial following a four-week trial (2018).
Trial counsel for agrochemical and agricultural biotechnology corporation in product liability action involving allegations that polychlorinated biphenyls caused the plaintiffs’ non-Hodgkin’s lymphoma. Multi-week trial in St. Louis, Missouri (2016).
Trial counsel for Johnson & Johnson in product liability case involving allegations that prescription antipsychotic medication caused plaintiff’s tardive dyskinesia (2014).
Trial Counsel in In re: Topamax Litigation, in the Court of Common Pleas, Philadelphia, PA (2014), involving allegations that a prescription anti-epileptic medication caused birth defects.
Trial Counsel (Co-Lead), Moser v. Atmos Energy Corp., et. al, Circuit Court of Hinds County, MS (2014) for construction company in case alleging that construction negligence caused plaintiff to suffer severe burns due to a natural gas explosion.
Trial Counsel in In re: Topamax Litigation, in the Court of Common Pleas, Philadelphia, PA (2013), involving allegations that a prescription anti-epileptic medication caused birth defects.
Lead Trial Counsel, English v. Rebelwood Apartments RP, LP et al. in wrongful death (premises liability) case in Hinds County, Mississippi; re-trial of case that had been reversed and remanded by Mississippi Supreme Court after $3 million verdict for Plaintiff prior to retention of Butler Snow; re-trial resulted in mistrial due to hung jury (2012).
Trial Counsel, Timothy R. Jones Jr. v. NES Equipment Services Corporation d/b/a NES Rentals; tried in Mississippi federal court; resulted in complete defense verdict (2009).
Christina Su v. Merck Sharp & Dohme Corp. – Product liability action involving prescription drug Fosamax. Atlantic County, New Jersey (2012).
Beare/Gaffney v. Johnson & Johnson, et al. – Six-week trial in the Superior Court of New Jersey, Atlantic County; resulted in complete defense verdicts (2011).
Rosenberg v. Merck – First Fosamax case to go to trial in New Jersey coordinated mass tort litigation; resulted in defense verdict (2011).
Louise Maley v. Merck & Co., Inc. – Trial in United States District Court for the Southern District of New York; resulted in defense verdict. (2010).
Shirley Boles v. Merck & Co., Inc. – First bellwether MDL trial in the Fosamax litigation (2009).
Panelist, “Recent Trends in the American Legal System,” ABA Regional Continuing Legal Education (CLE), Bristol-Myers Squibb Company, Lawrence Township, N.J., October 2017.
Co-Author, “Coordination among Federal Prosecutors, Regulators, and Civil Enforcers: Questions Abound, “ABA, Section of Litigation Mass Torts Newsletter, Vol. 14, No. 3. Summer 2016.
Speaker, “Connecting the Voir Dire and Opening Statement … And Why it Matters,” Trial Practice Seminar, FedEx Worldwide Headquarters, Memphis, Tenn., May 28, 2015.
Speaker, “Potential Criminal and Regulatory Implications of Pharmaceutical, Biotechnology, and Medical Device Products Liability Lawsuits,” Continuing Legal Education for global healthcare client, April 21, 2015.
Co-Author, “Social Media and the Legal Profession—Where Is the Ethical Line?” ABA Section of Litigation Mass Torts News & Developments, March 31, 2015.
Author, “Increasing Coordination among Federal Prosecutors, Regulators, and Civil Enforcers,” ABA Section of Litigation, Mass Torts Newsletter, Summer 2015.
Panelist, "The Dos and Don'ts of Trial Practice," ABA Environmental, Mass Torts & Products Liability Litigation Committees' Joint CLE Seminar, Aspen, Colo.,2015.
Author, “Diversity in Clinical Trials: Barriers Persist But So Does Progress,” Pro Te: Solutio, Vol. 7 No. 1, 29-33, March 2014.
Speaker, DRI’s 30th Annual Drug and Medical Device Seminar, Washington, D.C., “Effective Strategies for Neutralizing the Adverse Prescribing or Treating Physician at Deposition and Trial,” May 2014.
Author, “Effective Strategies for Neutralizing the Adverse Prescribing or Treating Physician at Deposition and Trial,” DRI’s 30th Annual Drug and Medical Device Seminar, May 2014.
Author, “FDA Considers Changes to its OTC Drug Review, Potentially Affecting Over 300,000 Drug Products,” ABA Section of Litigation Mass Torts Newsletter, April 30, 2014.
Speaker, Mississippi Black Caucus of Local Elected Officials, Mid-Winter Conference, 2010.
Contributor, “The Opening Statement: A Lasting Impression, The Commonwealth of Massachusetts v. Roy Smith (based on A Death in Belmont by Sebastian Junger)”, Mississippi Bar Litigation Section, January 2009.
Co-Author, “After the Recall: What Do We Do Now?” DRI’s In-House Defense Quarterly, Fall 2007.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.